One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Pain, Financial Hardship, and Employment in Cancer Survivors.
Blinder, Victoria S. MD, MSc 1,
doi : 10.1200/JCO.21.01812
Volume 40(1) pgs. 1-109 January 1, 2022
Importance of Population-Based Cancer Risk Information in the Care of Patients With Rare Genetic Disorders.
Plon, Sharon E. MD, PhD 1,,
doi : 10.1200/JCO.21.02251
Reporting of Racial Health Disparities Research: Are We Making Progress?.
Vince, Randy A. Jr MD, MS 1,; Eyrich, Nicholas W. MD, MS 1; Mahal, Brandon A. MD 2,; Stensland, Kristian MD, MPH 1; Schaeffer, Edward M. MD, PhD 3,; Spratt, Daniel E. MD 4,
doi : 10.1200/JCO.21.01780
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.
Naranbhai, Vivek MBChB, PhD, DPhil 1,2,3; Pernat, Claire A. BA 1; Gavralidis, Alexander MD 1,4; St Denis, Kerri J. BA 5; Lam, Evan C. BS 5; Spring, Laura M. MD 1,; Isakoff, Steven J. MD, PhD 1,; Farmer, Jocelyn R. MD, PhD 6,; Zubiri, Leyre MD 1,; Hobbs, Gabriela S. MD 1,; How, Joan MD 1,7; Brunner, Andrew M. MD 1,; Fathi, Amir T. MD 1,; Peterson, Jennifer L. BS 1; Sakhi, Mustafa MS 1; Hambelton, Grace BA 1; Denault, Elyssa N. BS 1; Mortensen, Lindsey J. BS 1; Perriello, Lailoo A. 1; Bruno, Marissa N. BS 1; Bertaux, Brittany Y. BS 1,; Lawless, Aleigha R. BS 1; Jackson, Monica A. BA 1; Niehoff, Elizabeth BS 1,; Barabell, Caroline BS 1; Nambu, Christian N. BS 1,; Nakajima, Erika 1; Reinicke, Trenton BA 1; Bowes, Cynthia NP 8; Berrios-Mairena, Cristhian J. MD 9; Ofoman, Onosereme BA 9,; Kirkpatrick, Grace E. BA 9; Thierauf, Julia C. MD 9; Reynolds, Kerry MD 1,; Willers, Henning MD 8,; Beltran, Wilfredo-Garcia MD, PhD 5,9,; Dighe, Anand S. MD, PhD 9; Saff, Rebecca MD 6; Blumenthal, Kimberly MD 6,; Sullivan, Ryan J. MD 1,; Chen, Yi-Bin MD 1,; Kim, Arthur MD 10,; Bardia, Aditya MD, MPH 1,; Balazs, Alejandro B. PhD 5; Iafrate, A. John MD, PhD 1,9,; Gainor, Justin F. MD 1,,
doi : 10.1200/JCO.21.01891
Impact of Pain on Employment and Financial Outcomes Among Cancer Survivors.
Halpern, Michael T. MD, PhD 1,; de Moor, Janet S. PhD, MPH 1,; Yabroff, K. Robin PhD, MBA 2
doi : 10.1200/JCO.20.03746
Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany.
Dutzmann, Christina M. MD 1; Spix, Claudia PhD 2; Popp, Isabell PhD 3; Kaiser, Melanie BS 2; Erdmann, Friederike PhD 2; Erlacher, Miriam MD 4,5,6; Dork, Thilo PhD 7; Schindler, Detlev MD 3; Kalb, Reinhard PhD 3; Kratz, Christian P. MD 1,
doi : 10.1200/JCO.21.01495
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenstrom's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.
Kersten, Marie Jose MD, PhD 1,,; Amaador, Karima MD 1; Minnema, Monique C. MD, PhD 2,; Vos, Josephine M. I. MD, PhD 1,; Nasserinejad, Kazem PhD 3; Kap, Marcel PhD 3; Kastritis, Efstathios MD, PhD 4,; Gavriatopoulou, Maria PhD 4,; Kraan, Willem MS 5; Chamuleau, Martine E. D. MD, PhD 6,; Deeren, Dries MD, PhD 7,; Tick, Lidwine W. MD, PhD 8; Doorduijn, Jeanette K. MD, PhD 9,; Offner, Fritz MD, PhD 10; Bohmer, Lara H. MD, PhD 11,; Liu, Roberto D. MS 1; Pals, Steven T. MD, PhD 5; Dimopoulos, Meletios A. MD, PhD 4,
doi : 10.1200/JCO.21.00105
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenstrom's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.
Buske, Christian MD 1,,; Tedeschi, Alessandra MD 2,; Trotman, Judith MBChB 3,; Garcia-Sanz, Ramon MD, PhD 4,; MacDonald, David MD 5,; Leblond, Veronique MD, PhD 6,; Mahe, Beatrice MD 7; Herbaux, Charles MD 8,; Matous, Jeffrey V. MD 9,; Tam, Constantine S. MBBS, MD 10,; Heffner, Leonard T. MD 11,; Varettoni, Marzia MD 12,; Palomba, M. Lia MD 13,; Shustik, Chaim MD 14,; Kastritis, Efstathios MD 15,; Treon, Steven P. MD, PhD 16,; Ping, Jerry PhD 17,; Hauns, Bernhard MD, PhD 17,; Arango-Hisijara, Israel MD 17,; Dimopoulos, Meletios A. MD 15,
doi : 10.1200/JCO.21.00838
Venetoclax in Previously Treated Waldenstrom Macroglobulinemia.
Castillo, Jorge J. MD 1,2,,; Allan, John N. MD 3,; Siddiqi, Tanya MD 4,; Advani, Ranjana H. MD 5,; Meid, Kirsten MPH 1; Leventoff, Carly BA 1; White, Timothy P. BA 1; Flynn, Catherine A. NP 1,; Sarosiek, Shayna MD 1,2,; Branagan, Andrew R. MD 2,6,; Demos, Maria G. BA 1; Guerrera, Maria L. MD 1; Kofides, Amanda BA 1; Liu, Xia BA 1,; Munshi, Manit BA 1; Tsakmaklis, Nicholas BA 1; Xu, Lian BA 1; Yang, Guang BA 1,; Patterson, Christopher J. BA 1; Hunter, Zachary R. PhD 1,2; Davids, Matthew S. MD 2,7,; Furman, Richard R. MD 3,; Treon, Steven P. MD, PhD 1,2,
doi : 10.1200/JCO.21.01194
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
Modest, Dominik Paul MD 1,2,,; Karthaus, Meinolf MD 3,; Fruehauf, Stefan MD 4,; Graeven, Ullrich MD 5,; Muller, Lothar MD 6,; Konig, Alexander Otto MD 7,; Fischer von Weikersthal, Ludwig MD 8,; Caca, Karel 9; Kretzschmar, Albrecht MD 10,; Goekkurt, Eray MD 11,12,; Haas, Siegfried MD 13; Kurreck, Annika MD 1,; Stahler, Arndt MD 1,; Held, Swantje MSc 15; Jarosch, Armin MD 15; Horst, David MD 2,15; Reinacher-Schick, Anke MD 16,; Kasper, Stefan MD 2,17,; Heinemann, Volker MD 2,18,; Stintzing, Sebastian MD 1,2,; Trarbach, Tanja MD 19,
doi : 10.1200/JCO.21.01332
Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
Acharya, Sahaja MD 1,2,; Guo, Yian MS 3; Patni, Tushar MS 3; Li, Yimei PhD 3; Wang, Chuang PhD 1; Gargone, Melissa MHS 1; Ashford, Jason M. MS 4; Wilson, Lydia PhD 1,; Faught, Austin PhD 1; Reddick, Wilburn E. PhD 5; Patay, Zoltan MD, PhD 5; Gajjar, Amar MD 6,; Conklin, Heather M. PhD 4; Merchant, Thomas E. DO, PhD 1,
doi : 10.1200/JCO.21.01480
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
Xu, Bin MD, PhD 1; Fuchs, Talia L. MD 2,3; Ahmadi, Sara MD 4; Alghamdi, Mohammed MD 1; Alzumaili, Bayan MD 1; Bani, Mohamed-Amine MD 5; Baudin, Eric MD 6,; Chou, Angela MD 2,3; De Leo, Antonio MD 7; Fagin, James A. MD 8,; Ganly, Ian MD, PhD 9; Glover, Anthony MD 3,10; Hartl, Dana MD 11,; Kanaan, Christina MD 5; Khneisser, Pierre MD 5; Najdawi, Fedaa MD 12,; Nigam, Aradhya MD 9; Papachristos, Alex MD 3,10; Repaci, Andrea MD 13; Spanheimer, Philip M. MD 9; Solaroli, Erica MD 14; Untch, Brian R. MD 9; Barletta, Justine A. MD 12; Tallini, Giovanni MD 7; Al Ghuzlan, Abir MD 5; Gill, Anthony J. MD 2,3; Ghossein, Ronald A. MD 1,
doi : 10.1200/JCO.21.01329
Perils of Ignoring Overall Survival in Interpreting the Myeloma Literature.
Mohyuddin, Ghulam Rehman MD; Goodman, Aaron M. MD; Knopf, Kevin MD
doi : 10.1200/JCO.21.01580
Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy.
Garfall, Alfred MD; Cohen, Adam MD; Stadtmauer, Edward MD; Susanibar-Adaniya, Sandra MD; Vogl, Dan MD; Waxman, Adam MD
doi : 10.1200/JCO.21.01754
Reply to G. R. Mohyuddin et al and A. Garfall et al.
Richardson, Paul G. MD; Moreau, Philippe MD
doi : 10.1200/JCO.21.02081
